# GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Study · id `cardio:ct-nct07228117` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07228117](<https://clinicaltrials.gov/study/NCT07228117>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07228117

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 389 participants.

## Technical summary

Registry record NCT07228117. Randomized; no masking; primary purpose other. Start 2026-02-02 (actual); primary completion 2027-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 389 participants (enrolled count; ClinicalTrials.gov record NCT07228117, source copy `cardio:ctgov-nct07228117-2026-09-02`, retrieved 2026-10-26)
- Started: 2026-02-02 (actual) (ClinicalTrials.gov record NCT07228117, source copy `cardio:ctgov-nct07228117-2026-09-02`, retrieved 2026-10-26)
- Primary completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT07228117, source copy `cardio:ctgov-nct07228117-2026-09-02`, retrieved 2026-10-26)
- Completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT07228117, source copy `cardio:ctgov-nct07228117-2026-09-02`, retrieved 2026-10-26)
- Countries: United States; Australia; New Zealand (ClinicalTrials.gov record NCT07228117, source copy `cardio:ctgov-nct07228117-2026-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07228117-2026-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
- Condition: Type 1 Diabetes Mellitus
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): MiniMed™ NMX8-AID System with DS5™/Simplera Sync™
- Lead sponsor: Medtronic MiniMed, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Medtronic MiniMed, Inc. (`cardio:org-medtronic-minimed-inc`)

## Provenance

Content hash: be618391eb44063526d66817e3c4107f2a0d1748511e8d98f73cbe53375eb54b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
